空气污染与大动脉疾病之间的联系:当前证据为未来的预防和治疗
Chayatorn Chansakaow1, Poon Apichartpiyakul1, Siriporn C Chattipakorn2,3,4
1Vascular Surgery Unit, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
International journal of medical sciences
|January 26, 2026
概括
空气污染,特别是细颗粒物 (PM2.5),加快了动脉动脉疾病,如动脉样硬化和动脉瘤. 暴露会引发炎症和细胞损伤,强调需要采取环境干预措施来保护心血管健康.
科学领域:
- 环境健康 环境健康
- 心血管科学 心血管科学
- 毒理学 毒理学 毒理学
背景情况:
- 空气污染是心血管疾病的主要环境风险因素.
- 大动脉对空气污染引起的损伤的敏感性需要进一步研究.
- 了解这些联系对于公共卫生和预防策略至关重要.
研究的目的:
- 审查和综合有关空气污染和大动脉疾病之间的联系的证据.
- 探索将空气污染暴露与大动脉损伤联系在一起的病理生理机制.
- 识别知识缺口和未来的研究方向.
主要方法:
- 在PubMed的综合文献搜索 (2007年12月 - 2024年5月).
- 包括体内,体外和临床研究.
- 对调查空气污染对大动脉病理生理学影响的研究进行分析.
主要成果:
- 细颗粒物 (PM2.5) 和柴油废气颗粒加速动脉样硬化,动脉瘤形成和剖析.
- 机制包括氧化应激,炎症,内皮功能障碍和血管重塑.
- 实验室研究表明,PM2.5诱导了人类大动脉内皮细胞中的细胞毒性.
- 临床数据表明,空气污染与大动脉化,动脉硬和血液动力学变化之间存在联系.
结论:
- 空气污染显著影响大动脉疾病的发展和进展.
- 涉及多个生物途径,强调了影响的复杂性.
- 需要进一步的研究来定义剂量反应关系,并确定环境干预的治疗目标.
相关概念视频
The Evidence for Evolution
47.7K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.7K
Parkinson's Disease: Treatment
1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment
854
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
854
Coronary Artery Disease IV: Preventive Measures
622
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Covalently Linked Protein Regulators
8.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.9K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
462
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
462


